Bladder transitional cell carcinoma – Basic Information

Go back

Bladder transitional cell carcinoma is a type of cancer that begins in the cells lining the urinary system. These special cells can stretch and shrink, allowing your bladder to fill and empty. When these cells become cancerous, they form tumors that can be treated successfully if caught early, though they have a tendency to return even after treatment.

Understanding Bladder Transitional Cell Carcinoma

This cancer is also known as urothelial carcinoma, and it develops in the urothelium, which is the tissue that lines the inside of your bladder, the tubes connecting your kidneys to your bladder (called ureters), and part of your kidney known as the renal pelvis. The cells in this lining are remarkable because they have the ability to change shape. When your bladder fills with urine, these cells stretch to accommodate the volume. When your bladder empties, they collapse back down. This flexibility is why they’re called transitional cells.[1]

Bladder transitional cell carcinoma represents the overwhelming majority of bladder cancer cases in the United States, accounting for approximately 90% of all bladder cancer diagnoses. It is the most common type of bladder cancer by far. In contrast, when this cancer appears in the kidneys, it makes up only about 5 to 10 percent of all kidney cancers, making it much less common in that location.[1][6]

Healthcare providers classify these cancers based on their grade and stage. The grade refers to how abnormal the cancer cells look under a microscope, while the stage describes how far the cancer has spread. Low-grade cancers are less aggressive and less likely to spread into deeper layers of the bladder or to other parts of the body. They are also less likely to come back after treatment. High-grade cancers, on the other hand, are more aggressive and have a greater tendency to invade deeper tissues, spread to lymph nodes and other organs, and return after treatment.[4]

⚠️ Important
Because transitional cells line many different parts of your urinary tract system, it’s possible to develop tumors in more than one place at the same time. If you’re diagnosed with transitional cell carcinoma in your bladder, your doctor should also check for tumors in other parts of your urinary system, such as the ureters or renal pelvis.[4]

Who Is Affected by This Cancer?

Bladder transitional cell carcinoma does not affect everyone equally. Certain groups of people face a much higher risk than others. Men are significantly more affected than women. In fact, men are four times more likely to develop bladder cancer compared to women. When it comes to kidney cancers, including those affecting the renal pelvis and ureters, men are twice as likely to be diagnosed as women.[1]

Age is another important factor in who gets this disease. The vast majority of people diagnosed with transitional cell carcinoma are over the age of 65. This means that as people get older, their risk of developing this cancer increases substantially. Younger adults can still develop the disease, but it is far less common in that age group.[1]

The disease is widespread enough that it ranks among the top ten most common cancers globally. Bladder cancer, which is predominantly transitional cell carcinoma, is associated with approximately 200,000 deaths per year in the United States alone, highlighting the serious public health burden of this condition.[6]

What Causes Bladder Transitional Cell Carcinoma?

Medical researchers still don’t fully understand what causes bladder transitional cell carcinoma in every case. However, they do know that the disease begins when a healthy transitional cell undergoes a change, or mutation, and transforms into a cancer cell. These cancer cells then multiply and form tumors. If left untreated, the cancer can spread beyond its original location to other parts of the body.[1]

What triggers these cellular changes is not entirely clear, but the disease is strongly linked to environmental factors. Bladder transitional cell carcinoma is considered a textbook example of a cancer that arises from exposure to harmful substances in the environment. Unlike some cancers that may be more influenced by genetics or random chance, this cancer has identifiable external causes that contribute to its development.[6]

Risk Factors That Increase Your Chances

Several factors have been clearly identified as increasing the risk of developing bladder transitional cell carcinoma. Understanding these risk factors can help people take steps to protect themselves.

Cigarette smoking is by far the most important risk factor. Smoking is thought to cause approximately half of all bladder cancer cases. When you smoke, harmful chemicals from the tobacco enter your bloodstream and are filtered by your kidneys. These toxic substances then collect in your urine and sit in your bladder for hours at a time, constantly exposing the bladder lining to carcinogens. This prolonged contact damages the transitional cells and increases the risk of cancer.[1][6]

Occupational chemical exposure is another major contributor. People who work in certain industries face higher risks due to their contact with specific chemicals. These industries include the manufacture of dyes, rubber, leather, paint, textiles, and hairdressing supplies. Workers in the petroleum industry and those exposed to aniline dyes and agrochemicals are also at increased risk. The chemicals in these substances can damage the DNA in transitional cells, leading to cancer over time.[1][6]

Certain medications and medical treatments can also raise the risk. Long-term misuse of pain medications, including some over-the-counter drugs, has been linked to transitional cell carcinoma. The chemotherapy drug cyclophosphamide produces metabolites that can predispose someone to developing bladder cancer. Previous radiation exposure to the pelvic area is another risk factor.[4][6]

Physical irritation of the bladder lining over long periods increases cancer risk. Chronic urinary stone disease, where stones repeatedly irritate the bladder, is one example. People who need long-term catheterization, such as those with paraplegia or multiple sclerosis, face higher risks because the catheter constantly irritates the bladder lining. Chronic bladder infections also create inflammation that can lead to cellular changes.[1][6]

Having a personal history of bladder cancer significantly increases the risk of developing transitional cell carcinoma in the renal pelvis and ureters. This is because the same risk factors that caused the first cancer are still present, and the transitional cells in different parts of the urinary tract share similar vulnerabilities.[1]

Recognizing the Symptoms

One of the challenges with bladder transitional cell carcinoma is that symptoms may not appear right away, especially in the early stages. However, when symptoms do develop, they are usually quite noticeable and should prompt a visit to a healthcare provider.

The most common and often the first noticeable symptom is blood in the urine, medically called hematuria. This is typically the earliest sign that something is wrong. The blood may make your urine appear pink, red, or cola-colored. Sometimes the blood is only visible under a microscope during a urine test, but other times it’s clearly visible to the naked eye.[1][3]

Changes in urination patterns are also common. You might find yourself needing to urinate more frequently than usual, or you may experience pain or a burning sensation when you urinate. These symptoms can be mistaken for a urinary tract infection, which is why it’s important to see a doctor for proper diagnosis.[1]

Other symptoms include persistent lower back pain that doesn’t go away with rest or treatment. Some people notice extreme fatigue that interferes with their daily activities. Unexplained weight loss, when you’re losing weight without trying, is another warning sign. If the cancer is in the kidney area, you might feel or see a lump or mass in your side or back, between your ribs and hips.[1]

⚠️ Important
Blood in your urine should never be ignored, even if it happens only once or doesn’t cause pain. While it can be caused by less serious conditions like infections or kidney stones, it can also be the first sign of bladder cancer. Always contact your healthcare provider if you notice blood in your urine so they can determine the cause.[3]

How to Reduce Your Risk

While not all cases of bladder transitional cell carcinoma can be prevented, there are concrete steps you can take to reduce your risk significantly.

The single most important action you can take is to quit smoking if you currently smoke. Because smoking is responsible for about half of all bladder cancer cases, eliminating this risk factor has a profound impact on your chances of developing the disease. If you’ve never smoked, don’t start. If you do smoke, talk to your doctor about programs, medications, or other strategies to help you quit. The benefits extend far beyond bladder cancer prevention and improve your overall health.[1]

Avoiding exposure to harmful chemicals is another protective measure. If you work in an industry where you’re exposed to chemicals known to cause bladder cancer, such as those used in dye manufacturing, rubber production, or painting, follow all safety protocols carefully. Use protective equipment, ensure good ventilation, and wash your hands thoroughly before eating or drinking. If possible, minimize your exposure to these substances.[1]

Staying well-hydrated may help lower your risk. Drinking plenty of fluids, especially water, dilutes the concentration of any harmful substances in your urine and reduces the amount of time these substances spend in contact with your bladder lining. Health experts suggest aiming for six to eight glasses of water per day. The more frequently you urinate, the less time potential carcinogens sit in your bladder.[6]

Eating a diet rich in fruits and vegetables may help keep your bladder healthy. A nutrient-rich diet not only supports overall health but may also reduce the risk of various types of cancer, including bladder cancer. Try to include at least five servings of fruits and vegetables in your daily diet, and eat whole grains several times a day.[20]

How the Disease Changes Normal Body Functions

To understand what happens in bladder transitional cell carcinoma, it helps to know how the urinary system normally works. Your kidneys filter your blood constantly, removing waste products and excess water to create urine. This urine travels from each kidney through a long tube called a ureter and collects in your bladder. Your bladder is a hollow, muscular organ that stores urine until you’re ready to release it. When you urinate, the urine leaves your body through a tube called the urethra.[5]

The transitional cells that line these structures have a unique ability. When your bladder fills with urine, these cells stretch and flatten to accommodate the increasing volume. When your bladder empties, they return to their original shape. This flexibility is crucial for the bladder to function properly.[5]

When cancer develops, normal transitional cells transform into cancer cells through genetic mutations. These changes affect how the cells grow and divide. Instead of following the normal life cycle of a cell, cancer cells multiply uncontrollably and don’t die when they should. As they accumulate, they form a tumor on the bladder wall or in the renal pelvis or ureter.[5]

The location and stage of the tumor determine what problems it causes. Tumors on the inner lining of the bladder that haven’t invaded deeper are called non-muscle-invasive. These are easier to treat but have a high rate of recurrence, meaning they often come back even after successful treatment. Evidence suggests that up to 70% of non-muscle-invasive bladder cancers may recur within two years of treatment.[18]

As tumors grow larger or invade deeper into the bladder wall, they can reach the muscular layer of the bladder. These are called muscle-invasive cancers and are more serious. They’re more likely to spread to lymph nodes and other organs. The tumor can also block the flow of urine from the kidneys, causing urine to back up and potentially damage the kidneys. This is why blood in the urine is such a common symptom—the tumor bleeds as it grows and sheds cells into the urine.[6]

If the cancer spreads beyond the urinary system, it typically goes first to nearby lymph nodes in the pelvis. From there, it can spread to distant organs. The most common sites of spread are the lungs, liver, and bones. In some cases, particularly after chemotherapy treatment, the cancer can spread to the brain. Unusual sites of spread have also been documented, including soft tissues in other parts of the body.[7]

The physical effects of the disease depend on where the cancer is and how far it has spread. Tumors in the bladder can cause frequent urination, pain during urination, and bleeding. Tumors in the kidney or ureters can cause pain in the side or back, and may block the flow of urine, leading to kidney damage. When cancer spreads to the bones, it can cause bone pain and increase the risk of fractures. Spread to the lungs may cause shortness of breath or coughing. As the disease advances, it can cause general symptoms like fatigue, loss of appetite, and unintended weight loss.

Ongoing Clinical Trials on Bladder transitional cell carcinoma

  • A study comparing erdafitinib delivery system to chemotherapy for patients with high-risk non-muscle-invasive bladder cancer who received BCG treatment

    Recruiting

    1 1 1 1
    Investigated diseases:
    Belgium France Germany Greece Italy The Netherlands +1
  • Study of nadofaragene firadenovec alone or with gemcitabine, docetaxel or pembrolizumab in adults with non-muscle invasive bladder cancer who did not respond to BCG therapy

    Recruiting

    1 1 1 1
    Investigated diseases:
    Czechia Denmark France Poland Spain
  • Study of Nadofaragene Firadenovec for Adults with Intermediate Risk Non-Muscle Invasive Bladder Cancer

    Recruiting

    1 1 1
    Investigated diseases:
    Czechia Denmark France Italy Poland Spain
  • Study on Mitomycin and BCG for Patients with Recurrent Non-Muscle Invasive Bladder Cancer

    Recruiting

    1 1 1 1
    Investigated diseases:
    Denmark Iceland Norway Sweden
  • Study Comparing Erdafitinib and Mitomycin for Patients with Intermediate-risk Non-muscle Invasive Bladder Cancer with FGFR Gene Alterations

    Recruiting

    1 1 1 1
    Investigated diseases:
    Austria Belgium Czechia Denmark France Germany +4
  • Study of Mitomycin-C with Electromotive Drug Administration before Surgery in Patients with Non-Muscle Invasive Bladder Cancer

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain
  • A study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer

    Not yet recruiting

    1 1 1
    Czechia Denmark France Germany Hungary Italy +3
  • Study on Avelumab for Patients with Advanced Urothelial Cancer After Initial Chemotherapy

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    The Netherlands
  • Study on the Safety and Effectiveness of Alpha1H for Adults with Non-Muscle Invasive Bladder Cancer Awaiting Tumor Removal Surgery

    Not recruiting

    Investigated diseases:
    Investigated drugs:
    Czechia
  • Study Comparing Gemcitabine and Mitomycin for Patients with Intermediate Risk Non-Muscle Invasive Bladder Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden

References

https://my.clevelandclinic.org/health/diseases/6239-transitional-cell-cancer

https://www.cancer.org/cancer/types/bladder-cancer/about/what-is-bladder-cancer.html

https://www.mayoclinic.org/diseases-conditions/bladder-cancer/symptoms-causes/syc-20356104

https://www.webmd.com/cancer/transitional-cell-cancer

https://www.cancer.gov/types/kidney/patient/transitional-cell-treatment-pdq

https://en.wikipedia.org/wiki/Transitional_cell_carcinoma

https://pmc.ncbi.nlm.nih.gov/articles/PMC1475968/

https://www.yalemedicine.org/clinical-keywords/urothelial-carcinoma-transitional-cell-carcinoma

https://www.mayoclinic.org/diseases-conditions/bladder-cancer/diagnosis-treatment/drc-20356109

https://www.ncbi.nlm.nih.gov/books/NBK66044/

https://my.clevelandclinic.org/health/diseases/6239-transitional-cell-cancer

https://www.cancer.gov/types/kidney/patient/transitional-cell-treatment-pdq

https://emedicine.medscape.com/article/281484-treatment

https://www.cancer.org/cancer/types/bladder-cancer/treating/by-stage.html

https://www.nhs.uk/conditions/bladder-cancer/treatment/

https://www.cancercare.org/publications/326-treatment_update_bladder_cancer

https://www.cancer.org/cancer/types/bladder-cancer/after-treatment/follow-up.html

https://www.cxbladder.com/us/blog/managing-life-after-bladder-cancer/

https://my.clevelandclinic.org/health/diseases/6239-transitional-cell-cancer

https://cinj.org/5-tips-boost-bladder-health

https://www.cancer.gov/types/bladder/coping

https://www.cancercare.org/publications/417-caregiving_for_a_loved_one_with_bladder_cancer

https://www.mayoclinic.org/diseases-conditions/bladder-cancer/diagnosis-treatment/drc-20356109

https://www.medanta.org/patient-education-blog/masterful-strategies-to-safeguard-your-bladder-during-cancer-treatment

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

What’s the difference between transitional cell carcinoma and urothelial carcinoma?

These are two names for the same disease. The cells were originally called “transitional cells” because of their ability to change shape, so the cancer was called transitional cell carcinoma. More recently, doctors have started calling them “urothelial cells” because they line the urothelium (the lining of the urinary tract), making the cancer urothelial carcinoma. Both terms refer to the exact same type of cancer.[1]

Does blood in my urine always mean I have bladder cancer?

No, blood in the urine can have many causes besides cancer, including urinary tract infections, kidney stones, strenuous exercise, or certain medications. However, because it can be a sign of bladder cancer, any instance of blood in your urine should be evaluated by a healthcare provider to determine the cause.[3]

If I quit smoking now, will it reduce my risk of bladder cancer?

Yes. Smoking is thought to cause about half of all bladder cancer cases, making it the single most important risk factor. Quitting smoking at any point reduces your risk, though the benefit increases the longer you’ve been smoke-free. Avoiding smoking is one of the most effective preventive measures you can take.[1][6]

Why does bladder cancer often come back after treatment?

Bladder cancer, especially the non-muscle invasive type, has a high recurrence rate because the entire lining of the urinary tract has been exposed to the same risk factors that caused the original cancer. Even after successful treatment of one tumor, other areas of the bladder lining may already have cellular changes that can develop into new tumors. This is why regular follow-up examinations are essential.[1][18]

Are men really at much higher risk than women?

Yes, there is a significant gender difference. Men are four times more likely to develop bladder cancer than women. For kidney cancers that involve the renal pelvis and ureters, men are twice as likely to be affected. The reasons for this difference aren’t completely understood but may relate to higher rates of smoking and occupational chemical exposure among men.[1]

🎯 Key takeaways

  • Bladder transitional cell carcinoma accounts for 90% of all bladder cancers in the United States, making it by far the most common type of bladder cancer.[1]
  • Cigarette smoking causes approximately half of all bladder cancer cases and is the single most important preventable risk factor.[6]
  • Blood in the urine is usually the first noticeable symptom and should always be evaluated by a doctor, even if it happens only once.[1]
  • Men are four times more likely than women to develop bladder cancer, and most people diagnosed are over age 65.[1]
  • Caught early, these cancers are easily treatable, but up to 70% may come back within two years, requiring lifelong monitoring.[1][18]
  • Workers exposed to chemicals in dyes, rubber, leather, paint, textiles, and petroleum industries face increased risk.[1]
  • Drinking plenty of water (six to eight glasses daily) may help reduce risk by diluting harmful substances in urine and reducing bladder contact time.[6]
  • Because transitional cells line multiple parts of the urinary tract, tumors can develop in more than one location simultaneously.[4]